Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy for central serous chorioretinopathy
jRCTs051180224Completed
- Start
- Jun 2016
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of verteporfin in Central Serous Chorioretinopathy (CSCR). Primary endpoint: Resolution of serous retinal detachment. Started Jun 2016; status: completed.
02
Drugs
verteporfin
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on jRCTs051180224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180224.